• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DDB1 E3 连接酶通过 CRY1 控制饮食果糖诱导的 ChREBPα 稳定和肝脂肪变性。

DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1.

机构信息

Department of Molecular & Integrative Physiology, University of Michigan Medical School, 1137 Catherine Street, Med Sci II 7712, Ann Arbor, MI 48109, USA.

Department of Molecular & Integrative Physiology, University of Michigan Medical School, 1137 Catherine Street, Med Sci II 7712, Ann Arbor, MI 48109, USA; Department of Infectious Diseases, The Second Xianya Hospital, Central South University, Changsha City 410083, Hunan Province, PR China.

出版信息

Metabolism. 2020 Jun;107:154222. doi: 10.1016/j.metabol.2020.154222. Epub 2020 Apr 1.

DOI:10.1016/j.metabol.2020.154222
PMID:32246987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7282961/
Abstract

Fructose over-consumption contributes to the development of liver steatosis in part by stimulating ChREBPα-driven de novo lipogenesis. However, the mechanisms by which fructose activates ChREBP pathway remain largely undefined. Here we performed affinity purification of ChREBPα followed by mass spectrometry and identified DDB1 as a novel interaction protein of ChREBPα in the presence of fructose. Depletion and overexpression of Ddb1 showed opposite effects on the ChREBPα stability in hepatocytes. We next tested the impact of hepatic Ddb1 deficiency on the fructose-induced ChREBP pathway. After 3-week high-fructose diet feeding, both Ddb1 liver-specific knockout and AAV-TBG-Cre-injected Ddb1 mice showed significantly reduced ChREBPα, lipogenic enzymes, as well as triglycerides in the liver. Mechanistically, DDB1 stabilizes ChREBPα through CRY1, a known ubiquitination target of DDB1 E3 ligase. Finally, overexpression of a degradation-resistant CRY1 mutant (CRY1-585KA) reduces ChREBPα and its target genes in the mouse liver following high-fructose diet feeding. Our data revealed DDB1 as an intracellular sensor of fructose intake to promote hepatic de novo lipogenesis and liver steatosis by stabilizing ChREBPα in a CRY1-dependent manner.

摘要

果糖摄入过多会刺激 ChREBPα 驱动的从头合成脂肪生成,从而导致肝脏脂肪变性。然而,果糖激活 ChREBP 通路的机制在很大程度上仍未确定。在这里,我们进行了 ChREBPα 的亲和纯化,然后进行了质谱分析,在果糖存在的情况下鉴定出 DDB1 是 ChREBPα 的一种新的相互作用蛋白。Ddb1 的耗竭和过表达对肝细胞中 ChREBPα 的稳定性表现出相反的影响。接下来,我们测试了肝 Ddb1 缺陷对果糖诱导的 ChREBP 通路的影响。在 3 周的高果糖饮食喂养后,Ddb1 肝特异性敲除和 AAV-TBG-Cre 注射的 Ddb1 小鼠的 ChREBPα、脂肪生成酶以及肝脏中的甘油三酯均显著降低。在机制上,DDB1 通过 CRY1 稳定 ChREBPα,CRY1 是 DDB1 E3 连接酶的已知泛素化靶标。最后,过表达一种不易降解的 CRY1 突变体 (CRY1-585KA) 可减少高果糖饮食喂养后小鼠肝脏中的 ChREBPα 和其靶基因。我们的数据揭示了 DDB1 作为果糖摄入的细胞内传感器,通过 CRY1 依赖性方式稳定 ChREBPα,从而促进肝脏从头合成脂肪生成和肝脂肪变性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/856ce2845e3a/nihms-1581433-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/aa6ab9cac9cd/nihms-1581433-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/3f5500a2efab/nihms-1581433-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/2c9d65b7be0f/nihms-1581433-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/a64bce67b236/nihms-1581433-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/8b0275cfa522/nihms-1581433-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/856ce2845e3a/nihms-1581433-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/aa6ab9cac9cd/nihms-1581433-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/3f5500a2efab/nihms-1581433-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/2c9d65b7be0f/nihms-1581433-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/a64bce67b236/nihms-1581433-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/8b0275cfa522/nihms-1581433-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/7282961/856ce2845e3a/nihms-1581433-f0006.jpg

相似文献

1
DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1.DDB1 E3 连接酶通过 CRY1 控制饮食果糖诱导的 ChREBPα 稳定和肝脂肪变性。
Metabolism. 2020 Jun;107:154222. doi: 10.1016/j.metabol.2020.154222. Epub 2020 Apr 1.
2
Tissue Specific Effects of Dietary Carbohydrates and Obesity on ChREBPα and ChREBPβ Expression.膳食碳水化合物和肥胖对ChREBPα和ChREBPβ表达的组织特异性影响。
Lipids. 2016 Jan;51(1):95-104. doi: 10.1007/s11745-015-4090-0. Epub 2015 Nov 2.
3
LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice.肝脏X受体α(LXRα)在小鼠摄入葡萄糖而非果糖时调节肝脏碳水化合物反应元件结合蛋白α(ChREBPα)的活性及脂肪生成。
Nutrients. 2017 Jun 29;9(7):678. doi: 10.3390/nu9070678.
4
DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.DDB1介导的CRY1降解促进肝脏中FOXO1驱动的糖异生作用。
Diabetes. 2017 Oct;66(10):2571-2582. doi: 10.2337/db16-1600. Epub 2017 Aug 8.
5
CUL4-DDB1-CDT2 E3 Ligase Regulates the Molecular Clock Activity by Promoting Ubiquitination-Dependent Degradation of the Mammalian CRY1.CUL4-DDB1-CDT2 E3连接酶通过促进哺乳动物CRY1的泛素化依赖性降解来调节分子钟活性。
PLoS One. 2015 Oct 2;10(10):e0139725. doi: 10.1371/journal.pone.0139725. eCollection 2015.
6
ChREBP regulates fructose-induced glucose production independently of insulin signaling.碳水化合物反应元件结合蛋白(ChREBP)独立于胰岛素信号传导调节果糖诱导的葡萄糖生成。
J Clin Invest. 2016 Nov 1;126(11):4372-4386. doi: 10.1172/JCI81993. Epub 2016 Sep 26.
7
LXRα Regulates ChREBPα Transactivity in a Target Gene-Specific Manner through an Agonist-Modulated LBD-LID Interaction.LXRα 通过激动剂调节的 LBD-LID 相互作用以靶基因特异性方式调节 ChREBPα 的转录活性。
Cells. 2020 May 13;9(5):1214. doi: 10.3390/cells9051214.
8
Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.生脂转录因子ChREBP介导果糖诱导的代谢适应性变化以预防肝毒性。
J Clin Invest. 2017 Jun 30;127(7):2855-2867. doi: 10.1172/JCI89934. Epub 2017 Jun 19.
9
A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.ChREBP 介导的 FGF21 分泌在肝脏果糖代谢中的关键作用。
Mol Metab. 2016 Nov 23;6(1):14-21. doi: 10.1016/j.molmet.2016.11.008. eCollection 2017 Jan.
10
The Mediator complex kinase module is necessary for fructose regulation of liver glycogen levels through induction of glucose-6-phosphatase catalytic subunit (G6pc).中介复合物激酶模块对于果糖通过诱导葡萄糖-6-磷酸酶催化亚基(G6pc)调节肝糖原水平是必需的。
Mol Metab. 2021 Jun;48:101227. doi: 10.1016/j.molmet.2021.101227. Epub 2021 Mar 31.

引用本文的文献

1
The Non-Canonical ChREBPα Activity Suppresses the Activation of Hepatic Stellate Cells and Liver Fibrosis by Antagonizing TGF-β-E2F1 Axis.非经典ChREBPα活性通过拮抗TGF-β-E2F1轴抑制肝星状细胞激活和肝纤维化。
Adv Sci (Weinh). 2025 Aug;12(29):e15032. doi: 10.1002/advs.202415032. Epub 2025 Jun 23.
2
Hepatocyte-specific loss of DDB1 attenuates hepatic steatosis but aggravates liver inflammation and fibrosis in MASH.DDB1 在肝细胞中的特异性缺失可减轻 MASH 中的肝脂肪变性,但可加重肝脏炎症和纤维化。
Hepatol Commun. 2024 Jun 27;8(7). doi: 10.1097/HC9.0000000000000474. eCollection 2024 Jul 1.
3
Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic.

本文引用的文献

1
mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars.mTOR 是一种参与简单糖代谢效应的关键蛋白。
Int J Mol Sci. 2019 Mar 5;20(5):1117. doi: 10.3390/ijms20051117.
2
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.果糖和糖:非酒精性脂肪性肝病的主要介质。
J Hepatol. 2018 May;68(5):1063-1075. doi: 10.1016/j.jhep.2018.01.019. Epub 2018 Feb 2.
3
Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways.果糖和葡萄糖可以通过不同的途径调节哺乳动物雷帕霉素靶蛋白复合物 1 和生脂基因的表达。
揭开代谢功能障碍相关脂肪性肝病中脂质代谢之谜:从机制到临床
Front Med (Lausanne). 2023 Nov 27;10:1294267. doi: 10.3389/fmed.2023.1294267. eCollection 2023.
4
Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets.ChREBP在肝脏和胰岛中的适应性和适应不良作用。
J Biol Chem. 2021 Jan-Jun;296:100623. doi: 10.1016/j.jbc.2021.100623. Epub 2021 Apr 2.
J Biol Chem. 2018 Feb 9;293(6):2006-2014. doi: 10.1074/jbc.M117.782557. Epub 2017 Dec 8.
4
Towards natural mimetics of metformin and rapamycin.迈向二甲双胍和雷帕霉素的天然模拟物。
Aging (Albany NY). 2017 Nov 15;9(11):2245-2268. doi: 10.18632/aging.101319.
5
DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.DDB1介导的CRY1降解促进肝脏中FOXO1驱动的糖异生作用。
Diabetes. 2017 Oct;66(10):2571-2582. doi: 10.2337/db16-1600. Epub 2017 Aug 8.
6
Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.生脂转录因子ChREBP介导果糖诱导的代谢适应性变化以预防肝毒性。
J Clin Invest. 2017 Jun 30;127(7):2855-2867. doi: 10.1172/JCI89934. Epub 2017 Jun 19.
7
The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer.变构 AKT 抑制剂 MK2206 可降低子宫内膜癌患者来源异种移植瘤的生长和侵袭。
Cancer Biol Ther. 2017 Dec 2;18(12):958-964. doi: 10.1080/15384047.2017.1281496. Epub 2017 Nov 27.
8
CRY2 and FBXL3 Cooperatively Degrade c-MYC.CRY2和FBXL3协同降解c-MYC。
Mol Cell. 2016 Nov 17;64(4):774-789. doi: 10.1016/j.molcel.2016.10.012. Epub 2016 Nov 10.
9
SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding.SREBP1c-CRY1 信号通过促进再喂养期间 FOXO1 的降解来抑制肝葡萄糖产生。
Nat Commun. 2016 Jul 14;7:12180. doi: 10.1038/ncomms12180.
10
The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis.通往代谢衰退的甜蜜之路:果糖与脂质合成
Trends Endocrinol Metab. 2016 Oct;27(10):719-730. doi: 10.1016/j.tem.2016.06.005. Epub 2016 Jul 4.